[go: up one dir, main page]

AU2002306952A1 - Detection and treatment of colorectal cancer - Google Patents

Detection and treatment of colorectal cancer

Info

Publication number
AU2002306952A1
AU2002306952A1 AU2002306952A AU2002306952A AU2002306952A1 AU 2002306952 A1 AU2002306952 A1 AU 2002306952A1 AU 2002306952 A AU2002306952 A AU 2002306952A AU 2002306952 A AU2002306952 A AU 2002306952A AU 2002306952 A1 AU2002306952 A1 AU 2002306952A1
Authority
AU
Australia
Prior art keywords
detection
treatment
colorectal cancer
colorectal
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002306952A
Inventor
Robert P. Szaro
Brynmor Watkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Matritech Inc
Original Assignee
Matritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matritech Inc filed Critical Matritech Inc
Publication of AU2002306952A1 publication Critical patent/AU2002306952A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
AU2002306952A 2001-03-28 2002-03-28 Detection and treatment of colorectal cancer Abandoned AU2002306952A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27947201P 2001-03-28 2001-03-28
US60/279,472 2001-03-28
PCT/US2002/009707 WO2002078636A2 (en) 2001-03-28 2002-03-28 Detection and treatment of colorectal cancer

Publications (1)

Publication Number Publication Date
AU2002306952A1 true AU2002306952A1 (en) 2002-10-15

Family

ID=23069112

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002306952A Abandoned AU2002306952A1 (en) 2001-03-28 2002-03-28 Detection and treatment of colorectal cancer

Country Status (2)

Country Link
AU (1) AU2002306952A1 (en)
WO (1) WO2002078636A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0317394A (en) 2002-12-20 2005-11-16 Roffmann La Roche Ag F Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
CA2526878A1 (en) * 2003-04-08 2004-10-21 Colotech A/S A method for detection of colorectal cancer in human samples
WO2005095979A1 (en) * 2004-03-30 2005-10-13 Roche Diagnostics Gmbh Use of protein proc as a marker for colorectal cancer
EP1833838A2 (en) * 2004-12-14 2007-09-19 Applera Corporation, Applied Biosystems Group Cationic liposomes comprising a charge neutral compound and a cationic phospholipid
CN101988875A (en) * 2010-09-03 2011-03-23 江苏省原子医学研究所 Sputum liquid-based treating fluid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593298B2 (en) * 2001-04-30 2003-07-15 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1690 daltons

Also Published As

Publication number Publication date
WO2002078636A3 (en) 2004-10-07
WO2002078636A2 (en) 2002-10-10

Similar Documents

Publication Publication Date Title
AU2003232485A1 (en) Neopeptides and methods useful for detection and treatment of cancer
AU2002307217A1 (en) Materials and methods for treatment of cancer and identification of anti-cancer compounds
WO2004104039A8 (en) Tumor antigens for prevention and/or treatment of cancer
AU2003247784A1 (en) Compositions and methods for treatment and detection of multiple cancers
AU2002257050A1 (en) Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
AU2001241877A1 (en) Methods for detection and treatment of neural cancers
AU2002313426A1 (en) Tumor antigens for prevention and/or treatment of cancer
AU2002341577A1 (en) Rapid and specific detection of campylobacter
AU2003274963A1 (en) Mda-7 and free radicals in the treatment of cancer
AU2002327639A1 (en) Detection and treatment of cancers of breast
AU2002340251A1 (en) Use of mx gtpases in the prognosis and treatment of cancer
AU2002306952A1 (en) Detection and treatment of colorectal cancer
AU2002327643A1 (en) Detection and treatment of cancers of the liver
AU2002258785A1 (en) Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
AU2002330724A1 (en) Diagnosis, prevention and treatment of cancer
AUPR644301A0 (en) Method and composition for treatment of cancer
AU2002366195A1 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
AU2001297571A1 (en) Detection and treatment of prostate cancer
AU2002305138A1 (en) Methods and materials for cancer treatment
AU2003231912A1 (en) Methods of detecting and treating prostate cancer
AU2002366364A1 (en) E2f and cancer therapy
AU2003209265A1 (en) Mrp9 and its use detecting and treating cancer
AU2003219563A1 (en) Methods of diagnosing and treating colorectal cancer
WO2003020115A9 (en) Methods and compositions for the detection of cancer
WO2004005463A9 (en) Tumor antigens bfa4 and bcy1 for prevention and/or treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase